{"id":11122,"date":"2025-11-17T10:37:57","date_gmt":"2025-11-17T09:37:57","guid":{"rendered":"https:\/\/www.tec4med.com\/news\/asebir-barcelona-2025\/"},"modified":"2026-04-30T07:00:10","modified_gmt":"2026-04-30T05:00:10","slug":"asebir-barcelona-2025","status":"publish","type":"news","link":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/","title":{"rendered":"ASEBIR Barcelona 2025"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row][vc_column][vc_column_text css=&#8221;&#8221;]<\/p>\n<h2>ASEBIR 2025 in Barcelona: Verbesserung der Zuverl\u00e4ssigkeit im Bereich der reproduktiven Gesundheit<\/h2>\n<p>[\/vc_column_text][vc_row_inner][vc_column_inner][vc_column_text css=&#8221;&#8221;]Vom 12. bis 14. November nahmen wir gemeinsam mit Cryoport Systems an der ASEBIR 2025 in Barcelona teil, wo unsere Experten vorstellten, wie unsere temperaturgesteuerten Echtzeit-\u00dcberwachungsl\u00f6sungen den sicheren und zuverl\u00e4ssigen Umgang mit empfindlichem Reproduktionsmaterial gew\u00e4hrleisten. Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.<\/p>\n<p>Mit mehr als 600 Experten unterstrich die ASEBIR einmal mehr die enge Verbindung zwischen Wissenschaft und Industrie. In den Diskussionen w\u00e4hrend der Veranstaltung wurde die Bedeutung von ethischer Verantwortung, Patientensicherheit sowie hochwertigen, transparenten Lieferketten f\u00fcr den Fortschritt in der Reproduktionsmedizin hervorgehoben.[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":"","author":{"name":"Robin Alexa","image":"https:\/\/www.tec4med.com\/wp-content\/uploads\/1683829032263.jpg","link":"https:\/\/www.tec4med.com\/de\/author\/robi\/"},"featured_media":10984,"template":"","news_cat":[],"class_list":["post-11122","news","type-news","status-publish","has-post-thumbnail","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ASEBIR Barcelona 2025 - Tec4med Lifescience GmbH<\/title>\n<meta name=\"description\" content=\"Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ASEBIR Barcelona 2025 - Tec4med Lifescience GmbH\" \/>\n<meta property=\"og:description\" content=\"Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/\" \/>\n<meta property=\"og:site_name\" content=\"Tec4med Lifescience GmbH\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-30T05:00:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"1\u00a0Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/\",\"url\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/\",\"name\":\"ASEBIR Barcelona 2025 - Tec4med Lifescience GmbH\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.tec4med.com\\\/wp-content\\\/uploads\\\/Image5.jpg\",\"datePublished\":\"2025-11-17T09:37:57+00:00\",\"dateModified\":\"2026-04-30T05:00:10+00:00\",\"description\":\"Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.tec4med.com\\\/wp-content\\\/uploads\\\/Image5.jpg\",\"contentUrl\":\"https:\\\/\\\/www.tec4med.com\\\/wp-content\\\/uploads\\\/Image5.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/asebir-barcelona-2025\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"ASEBIR Barcelona 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/#website\",\"url\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/\",\"name\":\"Tec4med Lifescience GmbH\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.tec4med.com\\\/de\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ASEBIR Barcelona 2025 - Tec4med Lifescience GmbH","description":"Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/","og_locale":"de_DE","og_type":"article","og_title":"ASEBIR Barcelona 2025 - Tec4med Lifescience GmbH","og_description":"Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.","og_url":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/","og_site_name":"Tec4med Lifescience GmbH","article_modified_time":"2026-04-30T05:00:10+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"1\u00a0Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/","url":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/","name":"ASEBIR Barcelona 2025 - Tec4med Lifescience GmbH","isPartOf":{"@id":"https:\/\/www.tec4med.com\/de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/#primaryimage"},"image":{"@id":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/#primaryimage"},"thumbnailUrl":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg","datePublished":"2025-11-17T09:37:57+00:00","dateModified":"2026-04-30T05:00:10+00:00","description":"Die Teilnehmer erfuhren, wie unsere Technologien IVF-Labore, Kryobiologie-Teams und Fachleute im Bereich der Reproduktionsmedizin dabei unterst\u00fctzen, eine konstante Temperaturkontrolle aufrechtzuerhalten, vollst\u00e4ndige Transparenz in der Lieferkette zu erreichen und strenge Anforderungen an R\u00fcckverfolgbarkeit und Compliance zu erf\u00fcllen.","breadcrumb":{"@id":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/#primaryimage","url":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg","contentUrl":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/www.tec4med.com\/de\/news\/asebir-barcelona-2025\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.tec4med.com\/de\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.tec4med.com\/de\/news\/"},{"@type":"ListItem","position":3,"name":"ASEBIR Barcelona 2025"}]},{"@type":"WebSite","@id":"https:\/\/www.tec4med.com\/de\/#website","url":"https:\/\/www.tec4med.com\/de\/","name":"Tec4med Lifescience GmbH","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.tec4med.com\/de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"}]}},"post_thumbnail":{"large":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg","medium":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5-300x225.jpg","full":"https:\/\/www.tec4med.com\/wp-content\/uploads\/Image5.jpg"},"blog_link":false,"category":[],"post_tag":[],"date_format":"17. Nov. 2025","featured":false,"_links":{"self":[{"href":"https:\/\/www.tec4med.com\/de\/wp-json\/wp\/v2\/news\/11122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tec4med.com\/de\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.tec4med.com\/de\/wp-json\/wp\/v2\/types\/news"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.tec4med.com\/de\/wp-json\/wp\/v2\/media\/10984"}],"wp:attachment":[{"href":"https:\/\/www.tec4med.com\/de\/wp-json\/wp\/v2\/media?parent=11122"}],"wp:term":[{"taxonomy":"news_cat","embeddable":true,"href":"https:\/\/www.tec4med.com\/de\/wp-json\/wp\/v2\/news_cat?post=11122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}